Outro Secures $7M to Build Healthcare’s First Neuroscience-Based Deprescribing Platform13. Oktober 2026
News Outro Secures $7M to Build Healthcare’s First Neuroscience-Based Deprescribing PlatformHealthradar13. Oktober 2026 What You Should Know Neuroscience-based deprescribing platform Outro announced that it has raised $7M in combined pre-seed and seed financing…
